Who are Cortone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Destriol, Delalutin, Prelone, Cortef, Cortifoam, Cortisol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cortisone-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Cortone — Competitive Intelligence Brief

Cortone (CORTISONE ACETATE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: alpha-Adrenergic Agonist [EPC]. Area: Oncology.

marketed alpha-Adrenergic Agonist [EPC] Corticosteroid-binding globulin Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Cortone (CORTISONE ACETATE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cortone TARGET	CORTISONE ACETATE		marketed	alpha-Adrenergic Agonist [EPC]	Corticosteroid-binding globulin	1950-01-01
Destriol	ESTRIOL		marketed	estriol	Corticosteroid-binding globulin, Olfactory receptor 51E2, Alpha-synuclein	2000-01-01
Delalutin	HYDROXYPROGESTERONE CAPROATE	Bristol-Myers Squibb	marketed	Progestin	Corticosteroid-binding globulin	1975-01-01
Prelone	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
Cortef	hydrocortisone	Generic (originally Merck/Upjohn)	marketed	Corticosteroid [EPC]	Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible	1952-01-01
Cortifoam	HYDROCORTISONE ACETATE	Pfizer	marketed	Corticosteroid	Corticosteroid-binding globulin	1951-01-01
Cortisol	Cortisol	University of Zurich	marketed		Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-11-19 — Cortef · 9717740 · Method of Use · US
2032-11-19 — Cortifoam · 9717740 · Method of Use · US
2033-01-10 — Cortifoam · 9675559 · Method of Use · US
2033-01-10 — Cortef · 9675559 · Method of Use · US
2034-05-12 — Cortef · 9649280 · Formulation · US
2034-05-12 — Cortifoam · 9649280 · Formulation · US
2043-02-23 — Cortef · 12133914 · Method of Use · US
2043-02-23 — Cortifoam · 11904046 · Formulation · US
2043-02-23 — Cortifoam · 12133914 · Method of Use · US
2043-02-23 — Cortef · 11904046 · Formulation · US

Sponsor landscape (alpha-Adrenergic Agonist [EPC] class)

· 2 drugs in this class
Pfizer Inc. · 2 drugs in this class
Provepharm Sas · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cortone — Competitive Intelligence Brief. https://druglandscape.com/ci/cortisone-acetate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab